Pnc Financial Services Group, Inc. Tarsus Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 210 shares of TARS stock, worth $9,972. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210
Previous 180
16.67%
Holding current value
$9,972
Previous $5,000
120.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
40.5MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$155 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$154 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$120 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$119 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$107 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.27B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...